Discovering effective drug candidates for preclinical
development requires innovative and reliable science; from disease models to tailored assays and robust high-throughput screening systems.
DiscoverHIT is an integrated, four-component drug discovery platform. Using Ncardia's recognized expertise in stem cell-based drug discovery experience, we enable you to bring predictive and translational human disease biology early into your drug discovery pipeline with speed and confidence.
DiscoverHIT is a full service HTS-screening platform based on human induced pluripotent stem cell technology. Efficacy of compound libraries are assayed and screened on your specific disease model. This comprehensive service is comprised of four integrated modules; disease modeling, manufacturing, assay development and high throughput phenotypic screening.